Trastuzumab versus observation in women with early breast cancer and CK-19 mRNA-positive circulating tumor cells (CTCs): A pilot randomized phase II study.

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

Annals of Oncology ◽

10.1093/annonc/mds020 ◽

2012 ◽

Vol 23 (7) ◽

pp. 1744-1750 ◽

Cited By ~ 103

Author(s):

V. Georgoulias ◽

V. Bozionelou ◽

S. Agelaki ◽

M. Perraki ◽

S. Apostolaki ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Early Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial

Annals of Oncology ◽

10.1093/annonc/mdy211 ◽

2018 ◽

Vol 29 (8) ◽

pp. 1777-1783 ◽

Cited By ~ 26

Author(s):

M. Ignatiadis ◽

S. Litière ◽

F. Rothe ◽

S. Riethdorf ◽

C. Proudhon ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Early Breast Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Faculty Opinions recommendation of Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.734565867.793581155 ◽

2020 ◽

Author(s):

David Potter

Keyword(s):

Breast Cancer ◽

Estrogen Receptor ◽

Neoadjuvant Therapy ◽

Early Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Estrogen Receptor Positive

Faculty Opinions recommendation of A randomized phase II trial investigating the effect of platelet function inhibition on circulating tumor cells in patients with metastatic breast cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718205732.793488396 ◽

2013 ◽

Author(s):

Davide Cattano

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Phase Ii ◽

Platelet Function ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Abstract OT2-6-10: DETECT IV – A multicenter, single arm, phase II study evaluating the efficacy of everolimus in combination with endocrine therapy in patients with HER2-negative, hormone-receptor positive metastatic breast cancer and HER2-negative circulating tumor cells (CTCs)

10.1158/0008-5472.sabcs13-ot2-6-10 ◽

2013 ◽

Author(s):

F Schochter ◽

C Melcher ◽

C Hagenbeck ◽

TWP Friedl ◽

B Jäger ◽

...

Keyword(s):

Breast Cancer ◽

Endocrine Therapy ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Phase Ii ◽

Hormone Receptor ◽

Phase Ii Study ◽

Metastatic Breast ◽

Hormone Receptor Positive

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-2781 ◽

2015 ◽

Vol 21 (12) ◽

pp. 2771-2779 ◽

Cited By ~ 48

Author(s):

Costanza Paoletti ◽

Yufeng Li ◽

Maria C. Muñiz ◽

Kelley M. Kidwell ◽

Kimberly Aung ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Phase Ii ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Phase Ii Trial ◽

Breast Cancer Patients ◽

Abstract P3-02-12: Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients with Metastatic Breast Cancer: A Randomized Phase II Trial

10.1158/0008-5472.sabcs10-p3-02-12 ◽

2010 ◽

Author(s):

R Roop ◽

M Naughton ◽

J Schneider ◽

P Lammers ◽

T Pluard ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Phase Ii ◽

Platelet Function ◽

Phase Ii Trial ◽

Metastatic Breast ◽

A Randomized Phase II Trial Investigating the Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients With Metastatic Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2013.08.006 ◽

2013 ◽

Vol 13 (6) ◽

pp. 409-415 ◽

Cited By ~ 18

Author(s):

Ryan P. Roop ◽

Michael J. Naughton ◽

Catherine Van Poznak ◽

Jochen G. Schneider ◽

Philip E. Lammers ◽

...

Keyword(s):

Breast Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Phase Ii ◽

Platelet Function ◽

Phase Ii Trial ◽

Metastatic Breast ◽

Faculty of 1000 evaluation for Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718021759.793480257 ◽

2013 ◽

Author(s):

Ana Maria Gonzalez-Angulo

Keyword(s):

Breast Cancer ◽

Progesterone Receptor ◽

Phase Ii ◽

Phase Ii Study ◽

Second Line ◽

Second Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii ◽

Positive Breast Cancer

Multicenter Phase II Study of Intraoperative Radiotherapy of Early Breast Cancer: Ipsilateral Tumor Recurrence

Annals of Surgical Oncology ◽

10.1245/s10434-019-07350-7 ◽

2019 ◽

Vol 26 (8) ◽

pp. 2428-2434 ◽

Cited By ~ 6

Author(s):

Masataka Sawaki ◽

Takeshi Miyamoto ◽

Tomomi Fujisawa ◽

Yoshiyuki Itoh ◽

Takeshi Ebara ◽

...

Keyword(s):

Breast Cancer ◽

Early Breast Cancer ◽

Phase Ii ◽

Tumor Recurrence ◽

Phase Ii Study ◽

Intraoperative Radiotherapy ◽

Multicenter Phase